Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J P McLaughlin

Showing results (31-40 of 45) with videos related to

Pageof 5
Sort By:
Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 31, 1997
Immunization with a syngeneic tumor infected with recombinant vaccinia virus expressing granulocyte-macrophage colony-stimulating factor (GM-CSF) induces tumor regression and long-lasting systemic immunityJ P McLaughlin, S Abrams, J Kantor, et al.
Cancer Research|August 15, 1995
Admixture of a recombinant vaccinia virus containing the gene for the costimulatory molecule B7 and a recombinant vaccinia virus containing a tumor-associated antigen gene results in enhanced specific T-cell responses and antitumor immunityJ W Hodge, J P McLaughlin, S I Abrams, et al.
The Science of the Total Environment|May 31, 2001
Retrospective assessment of historic radon concentrations in Norwegian dwellings by measuring glass implanted Po-210--an international field intercomparisonA Birovljev, R Falk, C Walsh, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|January 1, 1997
Adoptive immunotherapy as an in vivo model to explore antitumor mechanisms induced by a recombinant anticancer vaccineS I Abrams, J W Hodge, J P McLaughlin, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|January 1, 1997
Therapeutic antitumor response after immunization with an admixture of recombinant vaccinia viruses expressing a modified MUC1 gene and the murine T-cell costimulatory molecule B7J Akagi, J W Hodge, J P McLaughlin, et al.
Diseases of the Colon and Rectum|August 11, 2025
How Frequently Is Colorectal Cancer Recurrence Detected in Clinic?Gajan Srikumar, Scott J P McLaughlin, Jaxon Jebbink, et al.
ANZ Journal of Surgery|June 11, 2026
Potentially-Preventable Deaths Following Colorectal Surgery: A National Retrospective Cohort Study of Surgical MortalityCameron I Wells, Scott J P McLaughlin, Matthew J McGuiness, et al.
British Journal of Pharmacology|March 5, 2014
Alanine analogues of [D-Trp]CJ-15,208: novel opioid activity profiles and prevention of drug- and stress-induced reinstatement of cocaine-seeking behaviourJ V Aldrich, S N Senadheera, N C Ross, et al.
Bioconjugate Chemistry|November 1, 1991
A novel heterobifunctional linker for formyl to thiol couplingN D Heindel, H R Zhao, R A Egolf, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 1, 1999
Genetic alteration of phospholipase C beta3 expression modulates behavioral and cellular responses to mu opioidsW Xie, G M Samoriski, J P McLaughlin, et al.
Pageof 5

Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 31, 1997
Immunization with a syngeneic tumor infected with recombinant vaccinia virus expressing granulocyte-macrophage colony-stimulating factor (GM-CSF) induces tumor regression and long-lasting systemic immunityJ P McLaughlin, S Abrams, J Kantor, et al.
Cancer Research|August 15, 1995
Admixture of a recombinant vaccinia virus containing the gene for the costimulatory molecule B7 and a recombinant vaccinia virus containing a tumor-associated antigen gene results in enhanced specific T-cell responses and antitumor immunityJ W Hodge, J P McLaughlin, S I Abrams, et al.
The Science of the Total Environment|May 31, 2001
Retrospective assessment of historic radon concentrations in Norwegian dwellings by measuring glass implanted Po-210--an international field intercomparisonA Birovljev, R Falk, C Walsh, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|January 1, 1997
Adoptive immunotherapy as an in vivo model to explore antitumor mechanisms induced by a recombinant anticancer vaccineS I Abrams, J W Hodge, J P McLaughlin, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|January 1, 1997
Therapeutic antitumor response after immunization with an admixture of recombinant vaccinia viruses expressing a modified MUC1 gene and the murine T-cell costimulatory molecule B7J Akagi, J W Hodge, J P McLaughlin, et al.
Diseases of the Colon and Rectum|August 11, 2025
How Frequently Is Colorectal Cancer Recurrence Detected in Clinic?Gajan Srikumar, Scott J P McLaughlin, Jaxon Jebbink, et al.
ANZ Journal of Surgery|June 11, 2026
Potentially-Preventable Deaths Following Colorectal Surgery: A National Retrospective Cohort Study of Surgical MortalityCameron I Wells, Scott J P McLaughlin, Matthew J McGuiness, et al.
British Journal of Pharmacology|March 5, 2014
Alanine analogues of [D-Trp]CJ-15,208: novel opioid activity profiles and prevention of drug- and stress-induced reinstatement of cocaine-seeking behaviourJ V Aldrich, S N Senadheera, N C Ross, et al.
Bioconjugate Chemistry|November 1, 1991
A novel heterobifunctional linker for formyl to thiol couplingN D Heindel, H R Zhao, R A Egolf, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 1, 1999
Genetic alteration of phospholipase C beta3 expression modulates behavioral and cellular responses to mu opioidsW Xie, G M Samoriski, J P McLaughlin, et al.
Pageof 5